Merck & Co. Hits Target With Pneumococcal Vaccine, As Rivalry With Pfizer Continues

 
• By Alaric DeArment
  
Merck announced positive results for its pneumococcal disease vaccine, V116 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapeutic Category